The European Mental Health Week was a timely opportunity to shed light on the emotional strain that fertility treatments place on individuals and couples. By addressing both medical and emotional needs, a ReproUnion Innovation project aspires to support fertility treatment to make it more effective, less isolating, and more humane.

As one of the first commercial partners to access the ReproUnion Biobank & Infertility Cohort (RUBIC), Caerus Biotech is collaborating with Rigshospitalet to analyze samples from 1000 men, using the company’s MiOXSYS system designed to measure oxidative stress in semen.

At the event organized by ReproYoung the topic was male and female infertility – assessment and prognostic factors with talks by Anja Pinborg and Niels Jørgensen from Rigshospitalet.

This third episode of the Business Review Life Science podcast series brings together diverse perspectives from academia, industry, and healthcare and dives into the urgent topic of involuntary childlessness and explores how public-private collaboration is key to finding innovative fertility solutions.

Human Reproduction has published the findings from the largest existing study, to examine the link between semen quality and mortality, based on data from nearly 80,000 men. The main authors are also part of ReproUnion.

Dx4Life is the first start-up to emerge from the ReproUnion Innovation Platform, and the collaboration with RMC is a strong example of the translational research that ReproUnion fosters to bridge the gap between laboratory discoveries and clinical application.

At the workshop, co-organized with LU Innovation and Reproduktionmedicinskt Centrum (RMC), the clinicians explored an innovation framework which underlines the distinction that an invention isn’t truly an innovation until it’s successfully implemented.

ReproUnion hosted ReproYoung 2.0 for their re-launch and first ReproTalk event to explore parenthood – Is it important to have children? and what happens when biology becomes an enemy?

The ReproUnion Innovation Platform facilitated its first workshop to explore how cutting-edge research can be transformed into impactful, market-ready solutions. Innovation experts stories of successful research entrepreneurs and explained how to navigate differences in intellectual property (IP) rights in cross-border projects.

The funding from the Swedish Research Council will enable the research team to use the ReproUnion Biobank and Infertility Cohort (RUBIC) to analyze data from more than 500 couples across Denmark and Sweden, including a broad panel of hormone-disrupting chemicals, vitamins, and other biomarkers.